Get subscribed to our newsletter
Get interesting updates to your email inbox.
- Actor Rajkummar Rao, who injured his leg last month, says everything is on track now and he will soon be “back in action”.
Rajkummar Rao’s another film is set to release soon
“I’ve lost three days when I was in the hospital otherwise everything is on track. I have been dubbing and also promoting ‘Shaadi Mein Zaroor Aana’. The only unfortunate part is that we had to push the shooting of ‘Fanney Khan’. I feel bad for my team and producers Kriarj, ROMP and T-Series, but they have been so supportive and wonderful to me. I’ll be back in action…four to five weeks max,” he said.
The “Trapped” actor considers 2017 to be “certainly one of the best years of my career but I never planned it like this”.
“I was just shooting for all these films last year and this year and they all released. It was just a coincidence. But no complains. I feel very blessed that I’m part of all these wonderful films. I know not every year is going to be the same but I’ll try and keep doing different films and push myself with every film,” said the “Newton” star.
His another film is set to release soon.
“Yes, ‘Shaadi Mein Zaroor Aana’ is a very sweet romantic drama. It’s a first for me in this genre, but I had a really good time shooting for it. We had a great team and a really wonderful script. It gave me a lot of scope to perform as an actor because there are two different personality traits of my character in it,” said Rajkummar Rao.
It looks like another small town romance-comedy like “Bareilly Ki Barfi”. Isn’t that becoming a bit of a problem?
“‘Shaadi…’ is set in a small town, but it’s not our usual small town rom-coms. As an actor, I try to keep it as versatile as possible…I feel the small town rom-com has a charm and you can find so many characters in them that it’s fun to explore. Even if it’s a formula also, it’s a sweet formula to experiment with,” he said.
His other film “Omerta” has been received well at film festivals.
“‘Omerta’ is a very powerful film I feel. As an actor, it took a toll on my mental health. It wasn’t an easy character to portray, but Hansal (Mehta) sir pushed me to my limits.
“We made this film with a lot of honesty and passion, and it’s an antagonist story so that way it was a first for us. It feels great when audiences like our effort and can see the honesty in our films. Toronto, MAMI and Busan are all major festivals and I am really happy that we had such an overwhelming response,” he said.
How does he manage to be so effective in spite of doing so much work?
“I wish I knew if am effective or not. I always feel very nervous before starting any new film and probably it’s this fear only that pushes me to work harder every time. I try and live all my characters sincerely and try and make them believable,” he said.(IANS)
By Nikhila Natarajan
In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.
"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.
"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."
The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.
Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash
The study was conducted by Ferenc Huszar (Twitter, University of Cambridge), Sofia Ira Ktena (now at DeepMind Technologies), Conor O'Brien (Twitter), Luca Belli (Twitter), Andrew Schlaikjer (Twitter), and Moritz Hardt (UC Berkeley).
The questions probed were:
How much algorithmic amplification does political content from elected officials receive in Twitter's algorithmically ranked Home timeline versus in the reverse chronological timeline? Does this amplification vary across political parties or within a political party?
Are some types of political groups algorithmically amplified more than others? Are these trends consistent across countries?
Are some news outlets amplified more by algorithms than others? Does news media algorithmic amplification favour one side of the political spectrum more than the other?
Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. (IANS/ MBI)
Keywords: algorithmically, timeline, algorithmic, tweets, political, survey, twitter, study, germany, skew
Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".
Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.
"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.
"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)
Keywords: cowin, covid, india, people, Rohit bansal, Sonu kumar, vaccine, snapdeal, registrations
KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.
The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.
While the two injectables already went through trials in Europe and North America, this will be the first time they are tested in an African population for efficacy and safety in an African health care system.
Uganda is one of three African countries, along with Kenya and South Africa, which got approval from the WHO to carry out the trials. However, Kenya and South Africa have yet to acquire approvals to start their trials, expected by the end of the year.
Uganda and Kenya will both have three trial sites and there will be two in South Africa, with a total of 512 participants -- 202 from Uganda, 160 from Kenya and 150 from South Africa.
Dr. Ivan Mambule, the lead project researcher at the Joint Clinical Research Center, says participants will need one injection every two months.
"We are going to choose participants who are already on ART [anti-retroviral treatment] and are stable on ART. And we will randomize them to either continue on their normal treatment, which is the pill that they've been taking, or to switch them to this injectable. The injection is on the buttock," he expressed.
In this photo taken in Nov. 15, 2012 a patient, right, is attended to, at the US sponsored Themba Lethu, HIV/AIDS Clinic at the Helen Joseph hospital in Johannesburg, South Africa Image credit: VOA
Uganda has 1.4 million people living with HIV/AIDS. Barbara Kemigisa who is living with HIV and founded the Pill Power Foundation working with rural women, says the injectable drugs will increase adherence to treatment and ensure people get the right dosage.
"One of the things that affects adherence is the fact that people have to hide medicine. In the village, people are hiding medicine in the kitchen roof, in trees, in bushes, in a baby's shoe…If someone is wrapping the medicine in like five plastic bags and digs a hole in the garden and keeps the medicine there, by the time someone is taking that medicine, it's no longer medicine, it's poison," Kemigisa points out.
Nicholas Niwagaba, who has worked with young people living with HIV welcomes the trial, saying it will reduce the pill burden and fight stigma.
"Young people feel like, this is a lot of pills to take. Those who are on the first line, they will have to take one tablet a day. There are those who are on second line and they have to take more than one pill and they have to take it in the morning and in the evening. And of course, this requires you to have actually a balanced diet which is really a challenge for most of young people especially those from vulnerable communities," he says.
According to the WHO, there are 25.7 million people living with HIV in Africa. With only the pill currently available to manage the scourge, this injectable may come as a relief for people living with HIV/AIDS. (VOA/RN)
(This article is originally by Halima Athumani)
Keywords: HIV, WHO, Africa, Research, Uganda